Literature DB >> 2709323

Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method.

Y Kawashima1, T Niwa, T Handa, H Takeuchi, T Iwamoto, K Itoh.   

Abstract

A novel quasi-emulsion solvent diffusion method to prepare the controlled-release microspheres of ibuprofen with acrylic polymers has been developed. An ethanol solution of ibuprofen and acrylic resin was poured into aqueous medium with stirring. The finely dispersed ethanolic droplet-like coacervates formed in aqueous medium were gradually solidified and transformed into microspheres during agitation. The size of microspheres was determined by the concentrations of drug and polymer and the agitation speed of the system. The flowability, the packability, and the compressibility of the resultant microspheres were much improved compared with the raw crystals of the drug. The drug release rate from the microspheres could be controlled by the type and the concentration of polymer formulated. A unique principle of the present method and the resultant microspheres, having a matrix- or sponge-like texture, can provide characteristic advantages compared with a conventional reservoir-type device drug, like a microcapsule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2709323     DOI: 10.1002/jps.2600780118

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  17 in total

1.  Precise control of PLG microsphere size provides enhanced control of drug release rate.

Authors:  Cory Berkland; Martin King; Amanda Cox; Kyekyoon Kim; Daniel W Pack
Journal:  J Control Release       Date:  2002-07-18       Impact factor: 9.776

2.  Effects of process variables on micromeritic properties and drug release of non-degradable microparticles.

Authors:  Mitra Jelvehgari; Jaleh Barar; Ali Nokhodchi; Sanam Shadrou; Hadi Valizadeh
Journal:  Adv Pharm Bull       Date:  2011-07-30

Review 3.  Controlled release systems containing solid dispersions: strategies and mechanisms.

Authors:  Phuong Ha-Lien Tran; Thao Truong-Dinh Tran; Jun Bom Park; Beom-Jin Lee
Journal:  Pharm Res       Date:  2011-05-07       Impact factor: 4.200

4.  A novel method of preparing PLGA microcapsules utilizing methylethyl ketone.

Authors:  H Sah; M S Smith; R T Chern
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

5.  Study of particle rearrangement, compression behavior and dissolution properties after melt dispersion of ibuprofen, Avicel and Aerosil.

Authors:  Subrata Mallick; Saroj Kumar Pradhan; Muronia Chandran; Manoj Acharya; Tanmayee Digdarsini; Rajaram Mohapatra
Journal:  Results Pharma Sci       Date:  2011-05-17

6.  Development and evaluation of a floating multiparticulate gastroretentive system for modified release of AZT.

Authors:  Valquíria Miwa Hanai Yoshida; José Martins de Oliveira Junior; Marcos Moisés Gonçalves; Marta Maria Duarte Carvalho Vila; Marco Vinícius Chaud
Journal:  AAPS PharmSciTech       Date:  2011-05-12       Impact factor: 3.246

7.  Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.

Authors:  Rosario Pignatello; Nadia Ricupero; Claudio Bucolo; Francesco Maugeri; Adriana Maltese; Giovanni Puglisi
Journal:  AAPS PharmSciTech       Date:  2006-03-24       Impact factor: 3.246

8.  Studies on mefenamic acid microparticles: formulation, in vitro release, and in situ studies in rats.

Authors:  Ferhan Sevgi; Aysu Yurdasiper; Buket Kaynarsoy; Ezgi Turunç; Tamer Güneri; Ayfer Yalçin
Journal:  AAPS PharmSciTech       Date:  2009-01-29       Impact factor: 3.246

9.  A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose phthalate nanospheres.

Authors:  Y Kawashima; T Serigano; T Hino; H Yamamoto; H Takeuchi
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

10.  Surface-modified antiasthmatic dry powder aerosols inhaled intratracheally reduce the pharmacologically effective dose.

Authors:  Y Kawashima; T Serigano; T Hino; H Yamamoto; H Takeuchi
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.